Magnetic resonance imaging prognostic factors for survival and relapse in dogs with meningoencephalitis of unknown origin

被引:7
作者
Goncalves, Rita [1 ,2 ]
De Decker, Steven [3 ]
Walmsley, Gemma [1 ,2 ]
Maddox, Thomas W. [1 ,2 ]
机构
[1] Univ Liverpool, Small Anim Teaching Hosp, Dept Vet Sci, Neston, England
[2] Univ Liverpool, Inst Lifecourse & Med Sci, Dept Musculoskeletal & Ageing Sci, Liverpool, England
[3] Univ London, Royal Vet Coll, Dept Clin Sci & Serv, London, England
关键词
canine; MUO; MRI; outcome; prognosis; relapse; TERM-FOLLOW-UP; MULTIPLE-SCLEROSIS; GRANULOMATOUS MENINGOENCEPHALOMYELITIS; NECROTIZING MENINGOENCEPHALITIS; MRI PREDICTORS; BRAIN ATROPHY; DISABILITY; LESIONS; IMPAIRMENT; LOCATION;
D O I
10.3389/fvets.2024.1370882
中图分类号
S85 [动物医学(兽医学)];
学科分类号
0906 ;
摘要
Introduction Canine meningoencephalitis of unknown origin (MUO) is a debilitating disease associated with high mortality. The prognostic value of magnetic resonance imaging (MRI) findings for predicting survival at 12 months and long-term relapse remains uncertain.Methods This was a retrospective cohort study evaluating the prognostic value of different MRI variables using multivariable logistic regression and Cox proportional hazards analysis.Results In total, 138 dogs were presumptively diagnosed with MUO. The most common location for lesions identified on MRI were the white matter tracts of the corona radiata and corpus callosum, followed by the frontal, sensorimotor and temporal cortices. Lower T2 lesion load (p = 0.006, OR = 0.942, CI = 0.902-0.983) was associated with longer survival and higher T1 post-contrast lesion load (p = 0.023, OR = 1.162, CI = 1.021-1.322) was associated with relapse.Discussion This study has identified prognostic factors that may help identify dogs at higher risk of death and relapse and therefore guide treatment recommendations.
引用
收藏
页数:7
相关论文
共 42 条
  • [1] Retrospective evaluation of combined mycophenolate mofetil and prednisone treatment for meningoencephalomyelitis of unknown etiology in dogs: 25 cases (2005-2011)
    Barnoon, Itai
    Shamir, Merav H.
    Aroch, Itamar
    Bdolah-Abram, Tali
    Srugo, Itai
    Konstantin, Lilach
    Chai, Orit
    [J]. JOURNAL OF VETERINARY EMERGENCY AND CRITICAL CARE, 2016, 26 (01) : 116 - 124
  • [2] Bateman SW, 1999, J AM VET MED ASSOC, V215, P1463
  • [3] T2 lesion location really matters: a 10 year follow-up study in primary progressive multiple sclerosis
    Bodini, B.
    Battaglini, M.
    De Stefano, N.
    Khaleeli, Z.
    Barkhof, F.
    Chard, D.
    Filippi, M.
    Montalban, X.
    Polman, C.
    Rovaris, M.
    Rovira, A.
    Samson, R.
    Miller, D.
    Thompson, A.
    Ciccarelli, O.
    [J]. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2011, 82 (01) : 72 - 77
  • [4] Coates JR, 2007, J VET INTERN MED, V21, P100, DOI 10.1892/0891-6640(2007)21[100:PAATFT]2.0.CO
  • [5] 2
  • [6] Perspectives on Meningoencephalomyelitis of Unknown Origin
    Coates, Joan R.
    Jeffery, Nicholas D.
    [J]. VETERINARY CLINICS OF NORTH AMERICA-SMALL ANIMAL PRACTICE, 2014, 44 (06) : 1157 - +
  • [7] Clinical presentation, diagnostic findings, prognostic factors, treatment and outcome in dogs with meningoencephalomyelitis of unknown origin: A review
    Cornelis, I.
    Van Ham, L.
    Gielen, I.
    De Decker, S.
    Bhatti, S. F. M.
    [J]. VETERINARY JOURNAL, 2019, 244 : 37 - 44
  • [8] Prognostic factors for 1-week survival in dogs diagnosed with meningoencephalitis of unknown aetiology
    Cornelis, I.
    Volk, H. A.
    Van Ham, L.
    De Decker, S.
    [J]. VETERINARY JOURNAL, 2016, 214 : 91 - 95
  • [9] MRI Prognostic Factors in Multiple Sclerosis, Neuromyelitis Optica Spectrum Disorder, and Myelin Oligodendrocyte Antibody Disease
    Cortese, Rosa
    Giorgio, Antonio
    Severa, Gianmarco
    De Stefano, Nicola
    [J]. FRONTIERS IN NEUROLOGY, 2021, 12
  • [10] MRI contrast uptake in new lesions in relapsing-remitting MS followed at weekly intervals
    Cotton, F
    Weiner, HL
    Jolesz, FA
    Guttmann, CRG
    [J]. NEUROLOGY, 2003, 60 (04) : 640 - 646